Gene: ANKRD28
Official Full Name: ankyrin repeat domain 28provided by HGNC
Gene Summary: Predicted to be located in cytosol and nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO29626 | ANKRD28 Knockout cell line (HeLa) | Human | ANKRD28 | 1:3~1:6 | Negative | Online Inquiry |
KO29627 | ANKRD28 Knockout cell line (HCT 116) | Human | ANKRD28 | 1:2~1:4 | Negative | Online Inquiry |
KO29628 | ANKRD28 Knockout cell line (HEK293) | Human | ANKRD28 | 1:3~1:6 | Negative | Online Inquiry |
KO29629 | ANKRD28 Knockout cell line (A549) | Human | ANKRD28 | 1:3~1:4 | Negative | Online Inquiry |
ANKRD28 Gene Knockout Cell Lines are genetically modified cell lines engineered to specifically eliminate the expression of the ANKRD28 gene. ANKRD28 (ankyrin repeat domain 28) plays a crucial role in various cellular processes, including gene transcription regulation and signal transduction pathways. By knocking out this gene, researchers can study the absence of its function and assess its impact on cellular behavior, phenotypic changes, and downstream biological effects.
The key functionality of ANKRD28 Gene Knockout Cell Lines lies in their ability to provide a controlled environment for investigating the role of ANKRD28 in various biological contexts. The knockout mechanism involves targeted gene editing technologies such as CRISPR-Cas9, ensuring a precise deletion of the gene while minimizing off-target effects. This specificity allows researchers to observe the direct consequences of ANKRD28 depletion, aiding in revealing its involvement in cellular processes and potential disease mechanisms.
Scientifically, these cell lines are invaluable in both basic and applied research. In a clinical setting, they offer insights into gene-environment interactions, cancer biology, and developmental processes. They can serve as models for drug screening, therapeutic target validation, and understanding resistance mechanisms in cancer treatments. The ANKRD28 knockout cell lines are particularly beneficial for researchers aiming to elucidate the role of ANKRD28 in specific diseases or therapeutic contexts.
What sets our ANKRD28 Gene Knockout Cell Lines apart from alternatives is their validated knockout efficiency, comprehensive characterization, and the robust support provided for experimental design and execution. By ensuring reproducibility and reliability, our product allows researchers and clinicians to achieve substantive results faster and with greater confidence.
Our commitment to advancing scientific understanding is reflected in our expertise in genetic engineering and cell line development. With a dedication to providing high-quality biological products, our offerings empower researchers to accelerate their discoveries in molecular biology and pathology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.